Trail Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| TRAIL (TNFSF10) | |
|---|---|
| Gene Symbol | TRAIL (TNFSF10) |
| Full Name | TNF Superfamily Member 10 |
| Chromosome | 3q26.1 |
| NCBI Gene ID | 8743 |
| OMIM | 601647 |
| Ensembl ID | ENSG00000117586 |
| UniProt ID | P50591 |
| Associated Diseases | Alzheimer's Disease, Multiple Sclerosis, ALS |
TRAIL (TNF-Related Apoptosis-Inducing Ligand) is a member of the TNF superfamily encoded by the TNFSF10 gene. TRAIL is a type II transmembrane protein that can be cleaved to form a soluble ligand. TRAIL binds to four death receptors (DR4, DR5, DcR1, DcR2) and osteoprotegerin, with differential signaling outcomes. Upon binding to DR4/DR5, TRAIL activates extrinsic apoptosis through caspase-8. In the central nervous system, TRAIL has complex roles in neuronal survival and death. TRAIL is expressed in astrocytes, microglia, and neurons, and its expression is upregulated in Alzheimer's disease (particularly in amyloid-β-exposed cells), Parkinson's disease, and multiple sclerosis. TRAIL can induce apoptosis in dopaminergic neurons, contributing to PD pathogenesis. However, TRAIL also has non-apoptotic signaling roles in inflammation and cell survival. Therapeutic modulation of TRAIL signaling is being explored for cancer therapy and potentially for neurodegenerative diseases.
TRAIL (TNFSF10) encodes a cytokine belonging to the TNF superfamily that induces apoptosis in transformed and tumor cells. In the nervous system, TRAIL plays complex roles in neuronal survival, neuroinflammation, and immune surveillance. TRAIL binds to death receptors (DR4/TRAIL-R1, DR5/TRAIL-R2) to trigger apoptosis, while decoy receptors (DcR1, DcR2) can sequester TRAIL and prevent cell death.
Expressed in various brain regions including hippocampus, cortex, and cerebellum. Expressed in neurons, astrocytes, microglia, and oligodendrocytes. Expression is upregulated in response to inflammatory stimuli and in neurodegenerative disease states.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Alzheimer's Disease | Altered expression | Risk factor | Promotes neuronal apoptosis, modulates neuroinflammation |
| Multiple Sclerosis | Altered expression | Risk factor | Involved in oligodendrocyte death, demyelination |
| Amyotrophic Lateral Sclerosis | Altered expression | Risk factor | Contributes to motor neuron apoptosis |
The study of Trail Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.